Human CD4+ regulatory T cells and activation-induced tolerance.

[1]  A. Rudensky,et al.  Regulatory T cell lineage specification by the forkhead transcription factor foxp3. , 2005, Immunity.

[2]  M. Roncarolo,et al.  Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. , 2005, Blood.

[3]  P. Alard,et al.  Conversion of CD4 CD25 cells into CD4 CD25 regulatory T cells in vivo requires B7 costimulation, but not the thymus , 2004 .

[4]  M. Schilham,et al.  Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. , 2005, Human immunology.

[5]  M. A. Curotto de Lafaille,et al.  CD25− T Cells Generate CD25+Foxp3+ Regulatory T Cells by Peripheral Expansion1 , 2004, The Journal of Immunology.

[6]  C. Gianfrani,et al.  Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa , 2004, Gut.

[7]  M. Neurath,et al.  Cutting Edge: TGF-β Signaling Is Required for the In Vivo Expansion and Immunosuppressive Capacity of Regulatory CD4+CD25+ T Cells1 , 2004, The Journal of Immunology.

[8]  Y. Lévy,et al.  Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. , 2004, Blood.

[9]  H. Weiner,et al.  Induction of low dose oral tolerance in IL-10 deficient mice with experimental autoimmune encephalomyelitis. , 2004, Journal of autoimmunity.

[10]  G. Berry,et al.  Induction of T helper type 1–like regulatory cells that express Foxp3 and protect against airway hyper-reactivity , 2004, Nature Immunology.

[11]  L. Chess,et al.  An integrated view of suppressor T cell subsets in immunoregulation. , 2004, The Journal of clinical investigation.

[12]  K. Mills,et al.  Regulatory T cells: friend or foe in immunity to infection? , 2004, Nature Reviews Immunology.

[13]  T. Nomura,et al.  Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. , 2004, International immunology.

[14]  M. Schwartz,et al.  Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: A dialogue with microglia , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  C. Drake,et al.  Role of LAG-3 in regulatory T cells. , 2004, Immunity.

[16]  Angela Panoskaltsis-Mortari,et al.  Human Plasmacytoid Dendritic Cells Activated by CpG Oligodeoxynucleotides Induce the Generation of CD4+CD25+ Regulatory T Cells1 , 2004, The Journal of Immunology.

[17]  T. Ley,et al.  Human T regulatory cells can use the perforin pathway to cause autologous target cell death. , 2004, Immunity.

[18]  T. Malek,et al.  Tolerance, not immunity, crucially depends on IL-2 , 2004, Nature Reviews Immunology.

[19]  M. Schwartz,et al.  Self and non-self discrimination is needed for the existence rather than deletion of autoimmunity: the role of regulatory T cells in protective autoimmunity , 2004, Cellular and Molecular Life Sciences CMLS.

[20]  George Coukos,et al.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.

[21]  M. Schwartz,et al.  A common vaccine for fighting neurodegenerative disorders: recharging immunity for homeostasis. , 2004, Trends in pharmacological sciences.

[22]  L. Weiss,et al.  Dendritic cells generated in the presence of interferon-alpha stimulate allogeneic CD4+ T-cell proliferation: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells. , 2004, International immunology.

[23]  B. Stockinger,et al.  IL-10-Secreting Regulatory T Cells Do Not Express Foxp3 but Have Comparable Regulatory Function to Naturally Occurring CD4+CD25+ Regulatory T Cells 1 , 2004, The Journal of Immunology.

[24]  S. Zheng,et al.  Natural and Induced CD4+CD25+ Cells Educate CD4+CD25− Cells to Develop Suppressive Activity: The Role of IL-2, TGF-β, and IL-101 , 2004, The Journal of Immunology.

[25]  Peter R. Galle,et al.  Cutting Edge: TGF-β Induces a Regulatory Phenotype in CD4+CD25− T Cells through Foxp3 Induction and Down-Regulation of Smad7 , 2004, The Journal of Immunology.

[26]  Solange Akselrod,et al.  Autoimmunity as an immune defense against degenerative processes: a primary mathematical model illustrating the bright side of autoimmunity. , 2004, Journal of theoretical biology.

[27]  P. V. van Eeden,et al.  Timed Ablation of Regulatory CD4+ T Cells Can Prevent Murine AIDS Progression , 2004, The Journal of Immunology.

[28]  D. Accapezzato,et al.  Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection , 2004 .

[29]  E. Shevach,et al.  Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. , 2004, Seminars in immunology.

[30]  P. Nguyen,et al.  Antigen Nonspecific Suppression of T Cell Responses by Activated Stimulation-Refractory CD4+ T Cells 1 , 2004, The Journal of Immunology.

[31]  H. Nawata,et al.  TGF-β1 Plays an Important Role in the Mechanism of CD4+CD25+ Regulatory T Cell Activity in Both Humans and Mice , 2004, The Journal of Immunology.

[32]  E. Schmitt,et al.  Human CD4+CD25+ regulatory T cells and infectious tolerance. , 2004, Transplantation.

[33]  M. Moskowitz,et al.  Nasal Vaccination with Myelin Oligodendrocyte Glycoprotein Reduces Stroke Size by Inducing IL-10-Producing CD4+ T Cells1 , 2003, The Journal of Immunology.

[34]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[35]  D. Pardoll,et al.  Does the immune system see tumors as foreign or self? , 2003, Annual review of immunology.

[36]  A. Foussat,et al.  A Comparative Study between T Regulatory Type 1 and CD4+CD25+ T Cells in the Control of Inflammation 1 , 2003, The Journal of Immunology.

[37]  S. Ziegler,et al.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. , 2003, The Journal of clinical investigation.

[38]  H. Weiner,et al.  Immunotherapeutic Approaches to Alzheimer's Disease , 2003, Science.

[39]  C. Uyttenhove,et al.  Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase , 2003, Nature Medicine.

[40]  S. Akselrod,et al.  Vaccination with Dendritic Cells Pulsed with Peptides of Myelin Basic Protein Promotes Functional Recovery from Spinal Cord Injury , 2003, The Journal of Neuroscience.

[41]  N. Câmara,et al.  Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. , 2003, Blood.

[42]  A. Tedgui,et al.  Induction of a Regulatory T Cell Type 1 Response Reduces the Development of Atherosclerosis in Apolipoprotein E–Knockout Mice , 2003, Circulation.

[43]  P. Snow,et al.  Induction of Autoantigen-Specific Th2 and Tr1 Regulatory T Cells and Modulation of Autoimmune Diabetes1 , 2003, The Journal of Immunology.

[44]  L. Klein,et al.  In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Roncarolo,et al.  IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function. , 2003, Blood.

[46]  R. Barker,et al.  Regulatory T Cells Secreting IL-10 Dominate the Immune Response to EBV Latent Membrane Protein 11 , 2003, The Journal of Immunology.

[47]  M. Schwartz,et al.  Protective autoimmunity against the enemy within: fighting glutamate toxicity , 2003, Trends in Neurosciences.

[48]  H. Groux,et al.  Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. , 2003, Immunity.

[49]  Katsuaki Sato,et al.  Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. , 2003, Blood.

[50]  T. Curiel,et al.  Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity , 2003, Nature Medicine.

[51]  Katsuaki Sato,et al.  Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. , 2003, Immunity.

[52]  S. Akselrod,et al.  Autoimmunity as a special case of immunity: removing threats from within. , 2003, Trends in molecular medicine.

[53]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .

[54]  E. Hauben,et al.  Therapeutic vaccination for spinal cord injury: helping the body to cure itself. , 2003, Trends in pharmacological sciences.

[55]  M. Roncarolo,et al.  Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells. , 2003, Novartis Foundation symposium.

[56]  J. Brouwers,et al.  A Novel Host-Parasite Lipid Cross-talk , 2002, The Journal of Biological Chemistry.

[57]  C. Elson,et al.  Bacterial-Reactive T Regulatory Cells Inhibit Pathogenic Immune Responses to the Enteric Flora1 , 2002, The Journal of Immunology.

[58]  Manuela Battaglia,et al.  Human CD25+CD4+ T Suppressor Cell Clones Produce Transforming Growth Factor β, but not Interleukin 10, and Are Distinct from Type 1 T Regulatory Cells , 2002, The Journal of experimental medicine.

[59]  Michal Schwartz,et al.  Neuroprotective autoimmunity: Naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[60]  A. Hoerauf,et al.  Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). , 2002, Microbes and infection.

[61]  G. Berry,et al.  Antigen-specific regulatory T cells develop via the ICOS–ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity , 2002, Nature Medicine.

[62]  L. Sollid.  Coeliac disease: dissecting a complex inflammatory disorder , 2002, Nature Reviews Immunology.

[63]  N. Netzer,et al.  Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading. , 2002, The Journal of clinical investigation.

[64]  T. Eberlein,et al.  Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma1 , 2002, The Journal of Immunology.

[65]  David Klatzmann,et al.  CD4+CD25+ Immunoregulatory T Cells , 2002, The Journal of experimental medicine.

[66]  M. Roncarolo,et al.  Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines , 2002, European journal of immunology.

[67]  A. Enk,et al.  Infectious Tolerance , 2002, The Journal of experimental medicine.

[68]  G. Rook,et al.  Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells , 2002, Nature Medicine.

[69]  Ethan M. Shevach,et al.  CD4+CD25+ suppressor T cells: more questions than answers , 2002, Nature Reviews Immunology.

[70]  C. June,et al.  Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell Proliferation1 , 2002, The Journal of Immunology.

[71]  A. Enk,et al.  CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. , 2002, Blood.

[72]  K. Mills,et al.  CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. , 2002, The Journal of infectious diseases.

[73]  David F. Richards,et al.  In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines , 2002, The Journal of experimental medicine.

[74]  K. Mills,et al.  Pathogen-specific T Regulatory 1 Cells Induced in the Respiratory Tract by a Bacterial Molecule that Stimulates Interleukin 10 Production by Dendritic Cells , 2002, The Journal of experimental medicine.

[75]  E. Agranov,et al.  Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease. , 2001, The Journal of clinical investigation.

[76]  M. Roncarolo,et al.  Type 1 T regulatory cells , 2001, Immunological reviews.

[77]  Y. Tokura,et al.  Interleukin‐10 expressed at early tumour sites induces subsequent generation of CD4+ T‐regulatory cells and systemic collapse of antitumour immunity , 2001, Immunology.

[78]  Sayuri Yamazaki,et al.  Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance , 2001, Immunological reviews.

[79]  D. Umetsu,et al.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen , 2001, Nature Immunology.

[80]  M. Roncarolo,et al.  Human Cd25+Cd4+ T Regulatory Cells Suppress Naive and Memory T Cell Proliferation and Can Be Expanded in Vitro without Loss of Function , 2001, The Journal of experimental medicine.

[81]  A. Enk,et al.  Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood , 2001, The Journal of experimental medicine.

[82]  H. Weiner,et al.  Protective Autoimmunity Is a Physiological Response to CNS Trauma , 2001, The Journal of Neuroscience.

[83]  R. de Waal Malefyt,et al.  IFN-α and IL-10 Induce the Differentiation of Human Type 1 T Regulatory Cells1 , 2001, The Journal of Immunology.

[84]  D. Mason,et al.  Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro , 2001, European journal of immunology.

[85]  M. Roncarolo,et al.  Differentiation of T Regulatory Cells by Immature Dendritic Cells , 2001, The Journal of experimental medicine.

[86]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[87]  M. Roncarolo,et al.  The role of different subsets of T regulatory cells in controlling autoimmunity. , 2000, Current opinion in immunology.

[88]  A. Enk,et al.  Induction of Interleukin 10–Producing, Nonproliferating Cd4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells , 2000, The Journal of experimental medicine.

[89]  R. Coffman,et al.  T Regulatory Cells 1 Inhibit a Th2-Specific Response In Vivo1 , 2000, The Journal of Immunology.

[90]  E. Agranov,et al.  Passive or Active Immunization with Myelin Basic Protein Promotes Recovery from Spinal Cord Contusion , 2000, The Journal of Neuroscience.

[91]  W. Strober,et al.  Activated Self-MHC-Reactive T Cells Have the Cytokine Phenotype of Th3/T Regulatory Cell 1 T Cells , 2000, The Journal of Immunology.

[92]  V. Boussiotis,et al.  IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. , 2000, The Journal of clinical investigation.

[93]  J. Bluestone,et al.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. , 2000, Immunity.

[94]  C. Albanesi,et al.  Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. , 2000, The Journal of investigative dermatology.

[95]  C. Orosz,et al.  Human allograft acceptance is associated with immune regulation. , 2000, The Journal of clinical investigation.

[96]  Fiona Powrie,et al.  An Essential Role for Interleukin 10 in the Function of Regulatory T Cells That Inhibit Intestinal Inflammation , 1999, The Journal of experimental medicine.

[97]  M. Sela,et al.  Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[98]  Irun R. Cohen,et al.  Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy , 1999, Nature Medicine.

[99]  H. Weiner,et al.  IL‐4 is a differentiation factor for transforming growth factor‐β secreting Th3 cells and oral administration of IL‐4 enhances oral tolerance in experimental allergic encephalomyelitis , 1998, European journal of immunology.

[100]  D. Zélénika,et al.  Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells. , 1998, Journal of immunology.

[101]  Ethan M. Shevach,et al.  CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production , 1998, The Journal of experimental medicine.

[102]  C. Akdis,et al.  Role of interleukin 10 in specific immunotherapy. , 1998, The Journal of clinical investigation.

[103]  A. Roberts,et al.  Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production. , 1998, Journal of immunology.

[104]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[105]  I. Proctor,et al.  CD4+ T cell down-regulation in human intestinal mucosa: evidence for intestinal tolerance to luminal bacterial antigens. , 1997, Journal of immunology.

[106]  J. Phillips,et al.  Tolerance and suppression in a primed immune system. , 1996, Transplantation.

[107]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[108]  H. Weiner,et al.  Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. , 1996, The Journal of clinical investigation.

[109]  R. Coffman,et al.  A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells , 1996, The Journal of experimental medicine.

[110]  H. Weiner,et al.  Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. , 1994, Science.

[111]  R. de Waal Malefyt,et al.  High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells , 1994, The Journal of experimental medicine.

[112]  T. Mosmann,et al.  Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[113]  T. Mosmann,et al.  Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. , 1990, Science.

[114]  J. D. de Vries,et al.  Autoreactive T cell clones specific for class I and class II HLA antigens isolated from a human chimera , 1988, The Journal of experimental medicine.